The University of Cambridge and the company DIOSynVax have completed the human clinical trial of a universal coronavirus ...
The global health community is locked in an urgent race against time as an Ebola epidemic continues to surge across Africa.
There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.
There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding ...
Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...
By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of ...
The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly ...
A vaccine won’t be coming soon to help quell the Ebola outbreak raging through the Democratic Republic of Congo. There are no existing vaccines targeted to the species of Ebola that is already ...
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a week ago and is already the third-largest on record. But it’s the 17th ...
The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...
This outbreak is being called "the perfect storm." How did it start, what are the characteristics of the strain that's causing it and how much of a threat is it to global health?